Birchview Capital, LP Gossamer Bio, Inc. Transaction History
Birchview Capital, LP
- $108 Million
- Q3 2024
A detailed history of Birchview Capital, LP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Birchview Capital, LP holds 138,176 shares of GOSS stock, worth $96,723. This represents 0.13% of its overall portfolio holdings.
Number of Shares
138,176
Previous 138,176
-0.0%
Holding current value
$96,723
Previous $124,000
9.68%
% of portfolio
0.13%
Previous 0.12%
Shares
9 transactions
Others Institutions Holding GOSS
# of Institutions
108Shares Held
167MCall Options Held
430KPut Options Held
519K-
Nea Management Company, LLC Timonium, MD18.1MShares$12.7 Million1.37% of portfolio
-
Siren, L.L.C. New York, NY13.3MShares$9.3 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$8.23 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$6.43 Million2.2% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$5.64 Million4.79% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $65.8M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...